Efficacy and Safety of Donepezil on Cognition Improvement in Patients with Ischemic Stroke
碩士 === 國立成功大學 === 臨床藥學研究所 === 88 === Background: The prevalence of dementia among victims of ischemic stroke is as high as 24.6% after the first stroke and that of cognitive decline is 61.7%. Cerebral hypoperfusion after stroke is considered the cause of vascular dementia (VaD). Cholin...
Main Authors: | Pi-Hsiu Lin, 林碧秀 |
---|---|
Other Authors: | Ming-Liang Lai |
Format: | Others |
Language: | zh-TW |
Published: |
2000
|
Online Access: | http://ndltd.ncl.edu.tw/handle/25291331474439709919 |
Similar Items
-
Meta-analysis of efficacy and safety of Donepezil in treating cognitive decline of Parkinson's disease
by: Qiu-Ping Li, et al.
Published: (2021-08-01) -
Comparison of cognitive decline medications of Alzheimer´s disease : Efficacy and safety of Donepezil, Galantamine, Rivastigmine and Memantine
by: Sarwary, Mariam
Published: (2017) -
Clinical efficacy and safety of donepezil in the treatment of Alzheimer’s disease in Chinese patients
by: Zhang N, et al.
Published: (2018-10-01) -
DW2009 Elevates the Efficacy of Donepezil against Cognitive Impairment in Mice
by: Dong-Yun Lee, et al.
Published: (2021-09-01) -
Electrocardiogram Changes of Donepezil Administration in Elderly Patients with Ischemic Heart Disease
by: Deguo Wang, et al.
Published: (2018-01-01)